BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7509726)

  • 21. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules.
    Smith DM; Bluestone JA; Jeyarajah DR; Newberg MH; Engelhard VH; Thistlethwaite JR; Woodle ES
    J Immunol; 1994 Aug; 153(3):1054-67. PubMed ID: 7913109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand.
    Hünig T; Tiefenthaler G; Meyer zum Büschenfelde KH; Meuer SC
    Nature; 1987 Mar 19-25; 326(6110):298-301. PubMed ID: 3102975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation.
    Bednarczyk JL; Carroll SM; Marin C; McIntyre BW
    J Cell Biochem; 1991 Jul; 46(3):206-18. PubMed ID: 1723066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to the T-cell receptor (CD3) induce LFA-1/Mac-1-dependent mononuclear cell adhesion to human arterial endothelium.
    Fyfe AI; Stevenson LW; Berliner JA; Fogelman AM
    J Heart Lung Transplant; 1994; 13(2):230-5. PubMed ID: 7913340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional regulation of CD6 expression on human T lymphocytes by phorbol ester.
    Bott CM; Doshi JB; Li LL; McMurtry SA; Sanders JL; Fox DA
    J Immunol; 1994 Jul; 153(1):1-9. PubMed ID: 8207228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
    Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
    Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.
    Vandenberghe P; Verwilghen J; Van Vaeck F; Ceuppens JL
    Immunology; 1993 Feb; 78(2):210-7. PubMed ID: 7682535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of human T lymphocyte coactivation with an alpha4 integrin antagonist peptide.
    McIntyre BW; Woodside DG; Caruso DA; Wooten DK; Simon SI; Neelamegham S; Revelle JK; Vanderslice P
    J Immunol; 1997 May; 158(9):4180-6. PubMed ID: 9126978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes.
    Singer NG; Richardson BC; Powers D; Hooper F; Lialios F; Endres J; Bott CM; Fox DA
    Immunology; 1996 Aug; 88(4):537-43. PubMed ID: 8881754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells.
    Ticchioni M; Deckert M; Mary F; Bernard G; Brown EJ; Bernard A
    J Immunol; 1997 Jan; 158(2):677-84. PubMed ID: 8992983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA
    Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of CD2-mediated human T cell activation: anti-CD8 monoclonal antibodies inhibit CD2-mediated rise in intracellular calcium.
    Franco MD; Nunes J; Lipcey C; Lopez M; Mawas C; Olive D
    Cell Immunol; 1993 Nov; 152(1):162-75. PubMed ID: 7902214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell stimulation via CD47: agonistic and antagonistic effects of CD47 monoclonal antibody 1/1A4.
    Waclavicek M; Majdic O; Stulnig T; Berger M; Baumruker T; Knapp W; Pickl WF
    J Immunol; 1997 Dec; 159(11):5345-54. PubMed ID: 9548474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regions of the CD8 molecule involved in the regulation of CD2-mediated activation.
    Franco MD; Nunès J; Boursier JP; Imbert J; Mawas C; Acuto O; Olive D
    Cell Immunol; 1994 Sep; 157(2):341-52. PubMed ID: 7520836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bivalent binding of an anti-CD3 antibody to Jurkat cells induces association of the T cell receptor complex with the cytoskeleton.
    Marano N; Holowka D; Baird B
    J Immunol; 1989 Aug; 143(3):931-8. PubMed ID: 2787352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptosis of activated CD8+/CD57+ T cells is induced by some combinations of anti-CD2 mAb.
    Rouleau M; Bernard A; Lantz O; Vernant JP; Charpentier B; Senik A
    J Immunol; 1993 Oct; 151(7):3547-56. PubMed ID: 7690806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD59 costimulation of T cell activation. CD58 dependence and requirement for glycosylation.
    Menu E; Tsai BC; Bothwell AL; Sims PJ; Bierer BE
    J Immunol; 1994 Sep; 153(6):2444-56. PubMed ID: 7521361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frontline: Optimal T cell activation requires the engagement of CD6 and CD166.
    Hassan NJ; Barclay AN; Brown MH
    Eur J Immunol; 2004 Apr; 34(4):930-40. PubMed ID: 15048703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
    Lin J; Yon RW; Chavin KD; Qin L; Woodward J; Ding Y; Yagita H; Bromberg JS
    Transplantation; 1995 Apr; 59(8):1162-71. PubMed ID: 7537394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.